| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | importazole | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | -0.038 | 0.2 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.062 | 0.2 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | phloretin | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | Sunitinib | FIMM | pan-cancer | AAC | 0.23 | 0.2 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |